Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Larson Electronics introduces EPCS-PBS-3PS.HOA-PLG explosion proof control station October 12, 2018 Australian Plastics Manufacturer to Build Its First U.S. Plant November 24, 2018 The End of Trust? The Advent of Blockchain in Manufacturing March 25, 2019